ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Scotch Creek Ventures Inc

Scotch Creek Ventures Inc (7S20)

0.0288
0.00
(0.00%)
Cerrado 05 Diciembre 3:00PM
Realtime Data

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.0288
Postura de Compra
0.0262
Postura de Venta
0.0312
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
0.0244 Rango de 52 semanas 0.0314
Precio Anterior
0.0288
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
4,787
Volumen financiero
-
Precio Promedio Ponderado
-

7S20 Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.001-3.355704697990.02980.03139990.024447870.03018567DE
4-0.001-3.355704697990.02980.03139990.024447870.03018567DE
12-0.001-3.355704697990.02980.03139990.024447870.03018567DE
26-0.001-3.355704697990.02980.03139990.024447870.03018567DE
52-0.001-3.355704697990.02980.03139990.024447870.03018567DE
156-0.001-3.355704697990.02980.03139990.024447870.03018567DE
260-0.001-3.355704697990.02980.03139990.024447870.03018567DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
17DArcadia Biosciences Inc
5.15 €
(99.61%)
10.94k
1KPAProtara Therapeutics Inc
5.90 €
(75.60%)
16.79k
1ZY0Medaro Mining Corp
0.17 €
(63.46%)
54.1k
TE9Teco 2030 ASA
0.0398 €
(61.79%)
1.04M
L7C2Windfall Geotek Inc
0.006 €
(50.00%)
18k
NL8Genesis Ai Corp
0.0056 €
(-58.82%)
10k
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
859
CNWCodon AG
0.0065 €
(-40.91%)
1.5k
BLEBluebird bio Inc
0.4205 €
(-40.13%)
233.06k
DW8Tantalex Lithium Resources Corp
0.0115 €
(-39.47%)
2k
D7GNel ASA
0.2679 €
(0.15%)
5.5M
AXIAtos SE
0.20 €
(-36.51%)
4.95M
PLUNPlug Power Inc
2.2955 €
(13.55%)
3.17M
R9BDeFi Technologies Inc
3.06 €
(-6.13%)
2.98M
TUI1Tui AG
8.318 €
(5.26%)
2.21M
band aid band aid 43 segundos hace
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 48 segundos hace
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 1 minuto hace
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 1 minuto hace
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 1 minuto hace
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 2 minutos hace
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 2 minutos hace
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ
Richard H2 Richard H2 3 minutos hace
Just in:

http://www.nashvillechanceryinfo.org/CaseDetail.aspx?CaseID=80738

IN THE CHANCERY COURT FOR THE STATE OF TENNESSEE
TWENTIETH JUDICIAL DISTRICT, DAVIDSON COUNTY – CASE No.23-1020-II

B&K ENERGY, LLC – Plaintiff
v
HOLCOMB ENE
BKH
Dr Quest Dr Quest 3 minutos hace
"Existing management has already for two years overstated the value of the Company by advancing the ~$10.00 per share NAV narrative. "

So with the current offer by Ready, the merger price comes in at 5.50+/share. That would be a erosion of value of 45% over two years. Over those same
MartinLutherKing MartinLutherKing 4 minutos hace
3.TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced initiation of its Pha
RNAZ
Gamco Gamco 5 minutos hace
style="font-size: 16px"From Gemini:
style="font-size: 16px"

style="font-size: 16px"The potential implications of Tesla's appeal for a UK global FRAND rate ruling against Avanci/InterDigital are significant and could reshape the landscape of patent licensing in the t
IDCC
Zorch305 Zorch305 5 minutos hace
Lots of goodluck with Multiple irons in the fire!!
RDAR
Dragonman1 Dragonman1 5 minutos hace
I never said I was looking at this Co For a pump and dump your a liar!
KEGS
northam43 northam43 5 minutos hace
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/5/kxaxx6_All_Cycles_Chart.png
MartinLutherKing MartinLutherKing 5 minutos hace
2. TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
May 29 2024 - 9:15AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer
RNAZ
No-Quarter No-Quarter 6 minutos hace
That's a new one for me. Added. Thx
PickStocks PickStocks 6 minutos hace
Quote: " style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"Chad and Doreen can’t tell you, I, or AZ anything."
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-fami
COOP
nowwhat2 nowwhat2 7 minutos hace
Oh no......Not again !

https://investorshub.advfn.com/uimage/uploads/2024/12/5/vxyosxrp_121212_5_hyper_CAPT_not_again.jpg



FOMO
XRPUSD
arizona1 arizona1 7 minutos hace
I absolutely can understand why the UHC president was murdered.

I don’t like that it happened, but I can understand why people would want him dead, given the reports of UHC denying coverage to patients, which in this day and age, can mean that those patients die for lack of treatment.
MartinLutherKing MartinLutherKing 7 minutos hace
1. TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cance
RNAZ
fwb fwb 9 minutos hace
NVDA will SUPPLY the HARDWARE (CHIPS)
The computers will be built by others.
PLTR will be one of the SOFTWARE Companies those Computers will run on that will help the companies using them to improve on efficiency
It's how all these companies will USE these products for their bus
NVDA PLTR
BeepBeepMF BeepBeepMF 10 minutos hace
that chart ❤️ what a beaut it is $RDAR
RDAR

Su Consulta Reciente

Delayed Upgrade Clock